Clinical Trials on First Relapse/Progression in Switzerland

Total 75 results

European Organisation for Research and Treatment...
Amgen

Withdrawn

Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma (RIGOLETTO)

First Progression of MGMT Promoter-methylated Glioblastoma

Spain, Switzerland
University Hospital Inselspital, Berne

Completed

Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity (PASP)

Aortic Valve Stenosis | Valvular Heart Disease | Aortic Valve Sclerosis | Stenosis Progression

Switzerland
University Hospital Inselspital, Berne

Withdrawn

Epacadostat, Cladribine and Cytarabine (ECC) in AML (ECC)

AML | Relapse

Switzerland
University Hospital Inselspital, Berne

Recruiting

Drug-screening in AML at Relapse for Targeted Treatment (DARTT-1)

AML

Switzerland
Schulthess Klinik

Completed

CMC I Stability Intraoperative

Joint Instability | Osteoarthritis Thumb | Arthrosis of First Carpometacarpal Joint

Switzerland
Kantonsspital Aarau

Unknown

Laparoscopic Sacropexy With Robot-Assisted Surgical System (RobPex)

Vaginal Vault Prolapse

Switzerland
Kantonsspital Aarau

Unknown

Laparoscopic Sacropexy: Comparison of Mesh Attachment (MeshPlace)

Vaginal Vault Prolapse

Switzerland
Schulthess Klinik

Completed

Touch on One Thumb, RSI on the Other Thumb: Which Surgery Shows Better Results

Joint Diseases | Osteoarthritis | Musculoskeletal Diseases or Conditions | Osteoarthritis Thumb | Arthrosis of First Carpometacarpal Joint

Switzerland
Klinik Valens

Active, not recruiting

Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up

Oncologic Disorders

Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis (INsIDER)

Multiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)

Switzerland
University Hospital Inselspital, Berne

Recruiting

Prophylactic Laparoscopic Suspension After McCall (LAPCALL)

Prolapse Pelvic

Switzerland
Nicolas C. Buchs

Unknown

Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction

Pelvic Organ Prolapse | Rectal Prolapse

Switzerland
David Scheiner
University of Zurich; ETH Zurich (Switzerland)

Unknown

Pelvic Floor Study: Biomechanical Properties of the Female Pelvic Floor

Pelvic Organ Prolapse

Switzerland
Kantonsspital Aarau

Completed

Laparoscopic Sacrocolpopexy: Long Term Follow-up

Vaginal Vault Prolapse

Switzerland
Kantonsspital Aarau

Recruiting

Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study (HysPex)

Uterus Prolapse

Switzerland
Roza Umarova

Recruiting

Post-stroke Cognitive Impairment (CogStroke)

Cognitive Performance | First-ever Ischemic Stroke

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse (LOLIPOP)

Quality of Life | Pelvic Organ Prolapse | Incontinence

Switzerland
Cantonal Hosptal, Baselland

Unknown

Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection

Colon Adenoma | Sigmoid Diverticulosis | Sigmoid Diverticulitis | Rectal Prolapse

Switzerland
Mundipharma-EDO GmbH

Terminated

Tinostamustine Conditioning and Autologous Stem Cell (TITANIUM1)

Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Progression

Switzerland, United States, Norway
Casa Sollievo della Sofferenza IRCCS
Neurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...

Completed

Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients (NSC-SPMS)

Secondary-progressive Multiple Sclerosis

Italy, Switzerland
Klinik Valens
Technische Universität Dortmund, Germany

Recruiting

The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS (CYPRO)

Exercise | Cardiorespiratory Fitness | Primary Progressive Multiple Sclerosis

Switzerland
Dr. med. Tanja Hülder

Completed

ProViS (Prolift+M and Vita Sexualis) Study (ProViS)

Pelvic Organ Prolapse

Germany, Switzerland
Novartis Pharmaceuticals

Terminated

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study (SWISSMASIA)

Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity

Switzerland
University Hospital, Basel, Switzerland

Active, not recruiting

Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis (SMSC)

Multiple Sclerosis

Switzerland
NeoChord

Recruiting

Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System (AcChord)

Heart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve Disease

Germany, Greece, Switzerland
University of Lugano

Completed

Interactive Sections Of An Internet-Based Intervention Increase Patient Empowerment: A Study With Chronic Back Pain Patients

Group 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive Features

Switzerland
Prof. Dr. Jörg Leuppi
Kantonsspital Baselland Bruderholz; Institut für Hausarztmedizin Basel

Recruiting

Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT)

Pulmonary Disease, Chronic Obstructive | Disease Exacerbation | Adverse Effect of Glucocorticoids and Synthetic Analogues

Switzerland
Dr. med. Carlo Cereda
University Hospital Inselspital, Berne; CLINICA HILDEBRAND CENTRO DI RIABILITAZIONE... and other collaborators

Unknown

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke (RECOMBINE)

Ischemic Stroke | First Ever Clinical Stroke | Subacute Phase | Persistent Hemiparesis of Upper Extremity

Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2017_13

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2016_37

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
Hoffmann-La Roche

Completed

Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.

Healthy Volunteer, Muscular Atrophy, Spinal

Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2017_27

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
University of Zurich
University Hospital, Zürich; Universitätsklinikum Hamburg-Eppendorf

Completed

Telephone-administered Relapse Prevention for Depression (NaTel)

Depressive Disorder

Germany, Switzerland
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Hannover Medical School
CytoSorbents, Inc

Recruiting

Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE)

Cytokine Release Syndrome | CAR-T

Germany, Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
University of Bern
University Hospital Inselspital, Berne; Swiss National Science Foundation

Terminated

Does an Integrative Neuro-psychotherapy Program Foster the Adjustment in Depressed Stroke Patients? A Randomized Controlled Study.

Adjustment Disorders | Non-progressive Brain Injury

Switzerland
Klinik Valens

Recruiting

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis (TIME)

Multiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor Symptoms

Switzerland
University Hospital, Basel, Switzerland
Swiss Foundation for the Study of Muscular Diseases

Completed

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Giant Cell Arteritis | Large Vessel Giant Cell Arteriitis

Switzerland
University Hospital Inselspital, Berne

Completed

Nutritional Assessment in Mitochondrial Cytopathy (NAMITO)

Mitochondrial Diseases | Mitochondrial Myopathies | Mitochondrial Cytopathies

Switzerland
Edwards Lifesciences
ICON plc

Terminated

Observational Registry on the HARPOON Device (REPLICATE)

Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse

Germany, Spain, Switzerland
Heidelberg University
Baxter Healthcare Corporation; Boehringer Ingelheim; Aventis Pharmaceuticals; European...

Completed

Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (ESCAPE)

Hypertension | Children | Chronic Renal Failure | Acquired Kidney Disease | Congenital Kidney Disease

Czech Republic, France, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Serbia, Sweden, Switzerland, Turkey
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)

Metastatic Non Small Cell Lung Cancer

Denmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
Amoneta Diagnostics SAS
Assistance Publique - Hôpitaux de Paris; University Hospital, Geneva; University... and other collaborators

Unknown

ADDIA Proof-of-Performance Clinical Study (ADDIA)

Frontotemporal Lobar Degeneration | Progressive Supranuclear Palsy (PSP) | Dementia With Lewy Bodies (DLB) | Corticobasal Degeneration (CBD) | Alzheimer Disease (AD) | Parkinson Disease Dementia (PDD)

Belgium, France, Italy, Switzerland, Turkey
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Active, not recruiting

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression (INTERCEPT-AMD)

Atrophy | Age Related Macular Degeneration | Prediction | Intermediate AMD

Portugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
Janssen Research & Development, LLC

Approved for marketing

Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

Brazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
Molecular Partners AG

Recruiting

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia | Acute | Relapsed | Myeloid

Netherlands, France, Lithuania, Switzerland
Kite, A Gilead Company

Recruiting

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)

Relapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell Leukemia

United States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
Swiss Group for Clinical Cancer Research

Active, not recruiting

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Leukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic Leukemia

Switzerland
University Hospital, Grenoble

Completed

Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease (META-DEM)

Healthy | Alzheimer Disease | Semantic Dementia

France, Switzerland

Clinical Trials on First Relapse/Progression in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations